Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells: Expert Opinion on Biological Therapy: Vol 5, No 4

Views

CrossRef citations to date

Altmetric

Abstract

The use of bacteria for anticancer purposes was first attempted over 100 years ago. Recently, several strains of Salmonella have been shown to possess anticancer activity and, interestingly, Salmonella possesses a unique propensity to track to tumour tissue invivo. This review presents the use of Salmonella for cancer im-munotherapy, including the distinguishing characteristics of this organism and preclinical as well as clinical data.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells

Information for

Open access

Opportunities

Help and information

Cancer immunotherapy based on the killing of Salmonella typhimurium-infected tumour cells

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature